Xianglong Tian

1.7k total citations · 1 hit paper
21 papers, 848 citations indexed

About

Xianglong Tian is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Xianglong Tian has authored 21 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 7 papers in Cancer Research. Recurrent topics in Xianglong Tian's work include RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Genetic factors in colorectal cancer (4 papers). Xianglong Tian is often cited by papers focused on RNA modifications and cancer (6 papers), Cancer-related molecular mechanisms research (6 papers) and Genetic factors in colorectal cancer (4 papers). Xianglong Tian collaborates with scholars based in China, Hong Kong and United States. Xianglong Tian's co-authors include Xiaoqiang Zhu, Jie Hong, Jing‐Yuan Fang, Chaoqin Shen, Tingting Yan, Haoyan Chen, Chenyang Yu, Yingying Cao, Yanru Ma and Baoqin Xuan and has published in prestigious journals such as Molecular Cancer, Cancer Letters and Medicine.

In The Last Decade

Xianglong Tian

19 papers receiving 844 citations

Hit Papers

m6A-dependent glycolysis enhances colorectal cancer progr... 2020 2026 2022 2024 2020 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xianglong Tian China 14 632 487 149 146 61 21 848
Jue‐Yu Zhou China 15 426 0.7× 278 0.6× 54 0.4× 110 0.8× 34 0.6× 42 591
Fanghui Ren China 15 504 0.8× 458 0.9× 76 0.5× 141 1.0× 41 0.7× 20 805
Jianchun Cai China 14 552 0.9× 445 0.9× 127 0.9× 133 0.9× 54 0.9× 39 810
Gongmin Zhu China 11 471 0.7× 265 0.5× 133 0.9× 206 1.4× 98 1.6× 16 765
Duoguang Wu China 17 680 1.1× 565 1.2× 182 1.2× 125 0.9× 37 0.6× 33 915
Yangfan Lv China 16 583 0.9× 359 0.7× 130 0.9× 205 1.4× 86 1.4× 31 892
Ella Liberzon Israel 8 313 0.5× 278 0.6× 177 1.2× 111 0.8× 45 0.7× 9 529
Yan Qiu China 17 315 0.5× 282 0.6× 97 0.7× 227 1.6× 38 0.6× 39 639
Jianqun Cai China 14 435 0.7× 290 0.6× 219 1.5× 146 1.0× 38 0.6× 25 768

Countries citing papers authored by Xianglong Tian

Since Specialization
Citations

This map shows the geographic impact of Xianglong Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianglong Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianglong Tian more than expected).

Fields of papers citing papers by Xianglong Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianglong Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianglong Tian. The network helps show where Xianglong Tian may publish in the future.

Co-authorship network of co-authors of Xianglong Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Xianglong Tian. A scholar is included among the top collaborators of Xianglong Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianglong Tian. Xianglong Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Tian, Xianglong, Guihua Liu, Linhua Ji, et al.. (2024). Histone-acetyl epigenome regulates TGF-β pathway-associated chemoresistance in colorectal cancer. Translational Oncology. 51. 102166–102166. 3 indexed citations
3.
Tong, Tianying, Jie Zhang, Xiaoqiang Zhu, et al.. (2022). Prognostic Autophagy-Related Model Revealed by Integrating Single-Cell RNA Sequencing Data and Bulk Gene Profiles in Gastric Cancer. Frontiers in Cell and Developmental Biology. 9. 729485–729485. 8 indexed citations
4.
Yan, Tingting, Chaoqin Shen, Penglei Jiang, et al.. (2021). Risk SNP-induced lncRNA-SLCC1 drives colorectal cancer through activating glycolysis signaling. Signal Transduction and Targeted Therapy. 6(1). 70–70. 46 indexed citations
5.
Zhu, Xiaoqiang, Xianglong Tian, Linhua Ji, et al.. (2021). A tumor microenvironment-specific gene expression signature predicts chemotherapy resistance in colorectal cancer patients. npj Precision Oncology. 5(1). 7–7. 33 indexed citations
6.
Shen, Chaoqin, Tingting Yan, Tianying Tong, et al.. (2020). ALKBH4 Functions as a Suppressor of Colorectal Cancer Metastasis via Competitively Binding to WDR5. Frontiers in Cell and Developmental Biology. 8. 293–293. 13 indexed citations
7.
Shen, Chaoqin, Baoqin Xuan, Tingting Yan, et al.. (2020). m6A-dependent glycolysis enhances colorectal cancer progression. Molecular Cancer. 19(1). 72–72. 312 indexed citations breakdown →
8.
Tian, Xianglong, Xiaoqiang Zhu, Wenying Meng, et al.. (2020). A 12-immune cell signature to predict relapse and guide chemotherapy for stage II colorectal cancer. Aging. 12(18). 18363–18383. 4 indexed citations
9.
Shen, Chaoqin, Tingting Yan, Zhenhua Wang, et al.. (2018). Variant of SNP rs1317082 at CCSlnc362 (RP11-362K14.5) creates a binding site for miR-4658 and diminishes the susceptibility to CRC. Cell Death and Disease. 9(12). 1177–1177. 23 indexed citations
10.
Zhu, Xiaoqiang, Xianglong Tian, Tiantian Sun, et al.. (2018). GeneExpressScore Signature: a robust prognostic and predictive classifier in gastric cancer. Molecular Oncology. 12(11). 1871–1883. 18 indexed citations
11.
Tian, Xianglong, Xiaoqiang Zhu, Tingting Yan, et al.. (2017). Recurrence‐associated gene signature optimizes recurrence‐free survival prediction of colorectal cancer. Molecular Oncology. 11(11). 1544–1560. 36 indexed citations
12.
Shen, Chaoqin, Tingting Yan, Wei Liu, et al.. (2017). High Expression of FAM83B Predicts Poor Prognosis in Patients with Pancreatic Ductal Adenocarcinoma and Correlates with Cell Cycle and Cell Proliferation. Journal of Cancer. 8(16). 3154–3165. 25 indexed citations
13.
Tian, Xianglong, Xiaoqiang Zhu, Tingting Yan, et al.. (2017). Differentially Expressed lncRNAs in Gastric Cancer Patients: A Potential Biomarker for Gastric Cancer Prognosis. Journal of Cancer. 8(13). 2575–2586. 42 indexed citations
14.
Zhu, Xiaoqiang, Xianglong Tian, Chenyang Yu, et al.. (2016). A long non-coding RNA signature to improve prognosis prediction of gastric cancer. Molecular Cancer. 15(1). 60–60. 141 indexed citations
15.
Zhu, Xiaoqiang, Xianglong Tian, Chenyang Yu, et al.. (2016). Increased risk of hemorrhage in metastatic colorectal cancer patients treated with bevacizumab. Medicine. 95(34). e4232–e4232. 17 indexed citations
16.
Huang, Wei, Xianglong Tian, Yunlin Wu, et al.. (2008). Suppression of gastric cancer growth by baculovirus vectormediated transfer of normal epithelial cell specific-1 gene. World Journal of Gastroenterology. 14(38). 5810–5810. 22 indexed citations
17.
Huang, Wei, et al.. (2007). Angiotensin II Type 1 Receptor Antagonist Suppress Angiogenesis and Growth of Gastric Cancer Xenografts. Digestive Diseases and Sciences. 53(5). 1206–1210. 42 indexed citations
18.
Huang, Wei, et al.. (2007). Angiotensin II Type 1 Receptor Expression in Human Gastric Cancer and Induces MMP2 and MMP9 Expression in MKN-28 Cells. Digestive Diseases and Sciences. 53(1). 163–168. 29 indexed citations
19.
Wang, Jun, Biao Li, Changping Cai, et al.. (2007). Efficient transduction of spiral ganglion neurons in vitro by baculovirus vectors. Neuroreport. 18(13). 1329–1333. 6 indexed citations
20.
Huang, Wei, et al.. (2006). Downregulation and CpG island hypermethylation of NES1/hK10 gene in the pathogenesis of human gastric cancer. Cancer Letters. 251(1). 78–85. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026